1 |
Wang JY, Gao H. Tusanqi and hepatic sinusoidal obstruction syndrome [J]. J Dig Dis, 2014, 15(3): 105-107.
|
2 |
McDonald GB, Hinds MS, Fisher LD, et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients [J]. Ann Intem Med, 1993, 118(4): 255-267.
|
3 |
Jones RJ, Lee KS, Beschomer WE, et al. Venoocclusive disease of the liver following bone marrow transplantation [J]. Transplantation, 1987, 44(6): 778-783.
|
4 |
中华医学会消化病学分会肝胆疾病协作组.吡咯生物碱相关肝窦阻塞综合征诊断和治疗专家共识意见(2017年,南京) [J].临床肝胆病杂志, 2017, 33(9): 1627-1637.
|
5 |
de Lédinghen V, Villate A, Robin M, et al. Sinusoidal obstruction syndrome [J]. Clin Res Hepatol Gastroenterol, 2020, 44(4): 480-485.
|
6 |
刘建伟,逄菲,王青.吡咯生物碱相关肝窦阻塞综合征1例报道[J].胃肠病学和肝病学杂志, 2020, 29(5): 593-595.
|
7 |
李胤蒴,保洁,徐芸. 16例吡咯生物烷生物碱相关肝窦阻塞综合征的临床病理分析[J].中华肝脏病杂志, 2020, 28(4): 332-337.
|
8 |
任晓非,诸葛宇征,陈世耀,等.土三七相关肝窦阻塞综合征的全国多中心临床调研分析[J].中华消化杂志, 2017, 37(8): 523-529.
|
9 |
王峻瑶,张国艳,朱元民,等.肝窦阻塞综合征9例的临床分析[J].首都医科大学学报, 2014, 35(5): 604-607.
|
10 |
Agrawal V, Ranganath P, Ervin KD, et al. Effect of Sirolimus levels between days 11 and 20 after allogeneic stem cell transplantation on the risk of hepatic sinusoidal obstruction syndrome [J]. Bone Marrow Transplant, 2021, 56(1): 121-128.
|
11 |
郭严,张世荣,文良志,等.我国吡咯烷生物碱致肝窦阻塞综合征的临床特征分析[J].临床肝胆病杂志, 2018, 34(6): 1277-1281.
|
12 |
杨小倩,李骞,叶进,等.吡咯烷生物碱导致的肝窦阻塞综合征的MRI特点[J].临床消化病杂志, 2019, 31(3): 129-132.
|
13 |
Takashi M, Hironori H, Katsunobu O, et al. Phosphodiesterase Ⅲ inhibitor attenuates rat sinusoidal obstruction syndrome through inhibition of platelet aggregation in Disse's space [J]. J Gastroenterol Hepatol, 2018, 33(4): 950-957.
|
14 |
朱成凯,张峰,诸葛宇征,等. 115例土三七致肝窦阻塞综合征的临床特点分析[J].中华消化杂志, 2017, 37(7): 448-452.
|
15 |
Petaja J, Pitkanen S, Vettenranta K. Serum tumor maker CA125 is an early and sensitive indicator of veno-occulusive disease in children undergoing bone marrow transplantiation [J]. Clin Res, 2000, 6(2): 531-535.
|
16 |
祖晓满,王春峰,张连峰,等.土三七致肝窦阻塞综合征53例临床特征与诊疗分析[J].中国实用医刊, 2019, 46(11): 4-8.
|
17 |
Li X, Yang X, Xu D, et al. Magnetic Resonance Imaging Findings in Patients With Pyrrolizidine Alkaloid-Induced Hepatic Sinusoidal Obstruction Syndrome [J]. Clin Gastroenterol Hepatol, 2017, 15(6): 955-957.
|
18 |
俞傲,吕维富,周春泽,等.肝窦阻塞综合征CT和MRI表现[J].中国介入影像与治疗学, 2020, 17(4): 220-223.
|
19 |
Liu F, Rong X, Guo H, et al. Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study [J]. BMC Gastroenterol, 2020, 20(1): 121-128.
|
20 |
Yang XQ, Ye J, Li X, et al. Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes [J]. World J Gastroenterol, 2019, 25(28): 3753-3763.
|